Company Filing History:

4 out of 1,929

Ajinomoto Co., Ltd.

patents

3 out of 212

Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai

patents

2 out of 237

Banyu Pharmaceutical Co. Ltd

patents

4. 1 out of 9

Daiichi Radioisotope Laboratories, Ltd.

patents

5. 1 out of 44

Microbial Chemistry Research Foundation

patents

where one patent can have more than one assignee

Years Active: 1978-1994

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5288898 - N-methylphenylserine alkyl ester derivatives and uses thereof (1994-02-22),

2. 4833268 - Threo-adrenalinecarboxylic acid, and the production and uses thereof (1989-05-23),

3. 4745067 - L-aminoacylases (1988-05-17),

4. 4699879 - Process for microbial production of an optically active (1987-10-13),

5. 4371514 - Radioimmunoassay of pterins and novel pterin derivatives useful therefor (1983-02-01),

6. 4191809 - Method of measuring enzymatic activity using novel peptide derivatives (1980-03-04),

7. 4191808 - Method of measuring dipeptidyl-amino-peptidase activity (1980-03-04),

8. 4147692 - Novel dipeptide derivatives, and method of measuring enzymatic activity (1979-04-03),

9. 4119620 - Novel dipeptide derivatives, salts thereof, and method of measuring (1978-10-10),

Title: Toshiharu Nagatsu: A Pioneer in Pharmaceutical Innovation

Introduction:

Toshiharu Nagatsu, a renowned inventor hailing from Yokohama, Japan, has left an indelible mark in the world of pharmaceutical innovation through his relentless pursuit of creating groundbreaking compounds for therapeutic use. With a total of 9 patents to his name, Nagatsu's commitment to advancing medical science is truly commendable.

Latest Patents:

Nagatsu's latest patents include the development of N-methylphenylserine alkyl ester derivatives and their uses in treating disorders related to adrenergic functions. These compounds show promise in stimulating the central nervous system's adrenergic functions, offering potential therapeutic benefits for various conditions. Additionally, his work on threo-adrenalinecarboxylic acid presents new avenues for treating Parkinson's disease and mental depression.

Career Highlights:

Throughout his illustrious career, Toshiharu Nagatsu has displayed a remarkable dedication to innovation in the field of pharmaceuticals. His role in companies such as Ajinomoto Co., Ltd. and the Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai has been instrumental in driving forward research and development efforts in drug discovery.

Collaborations:

Nagatsu has had the privilege of working alongside esteemed colleagues such as Hamao Umezawa and Tomio Takeuchi, whose contributions have further enriched the landscape of pharmaceutical research. Together, they have pioneered new methodologies and compounds that have the potential to revolutionize the treatment of various diseases.

Conclusion:

In conclusion, Toshiharu Nagatsu's contributions to pharmaceutical innovation underscore his status as a true pioneer in the field. His passion for creating novel compounds with therapeutic benefits showcases a deep-seated commitment to improving the quality of life for individuals around the world. Nagatsu's legacy serves as an inspiration for future inventors and innovators seeking to make a positive impact on healthcare and well-being.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.